# Actuation Indicator Trial in Patients With COPD

> **NCT00928746** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 142 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DEVICE:** Ipratropium bromide

## Key facts

- **NCT ID:** NCT00928746
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2009-08
- **Final completion:** —
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2014-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00928746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00928746, "Actuation Indicator Trial in Patients With COPD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00928746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*